Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced key data from the SVS TCAR Surveillance Project and ROADSTER-2 study will be presented at the upcoming Society for Vascular Surgery 2019 Vascular Annual Meeting (VAM), June 12-15
SUNNYVALE, Calif. – June 4, 2019 – Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced key data from the SVS TCAR Surveillance Project and ROADSTER-2 study will be presented at the upcoming Society for Vascular Surgery 2019 Vascular Annual Meeting (VAM), June 12-15 at the Gaylord National Resort & Convention Center in National Harbor, Maryland. Data from the Society for Vascular Surgery’s TCAR Surveillance Project, launched in 2016 to obtain real-world comparative outcomes of TCAR and other carotid artery treatments from centers participating in the Vascular Quality Initiative (VQI), will be featured in podium and poster presentations, including: Final results of the ROADSTER-2 study will be featured in the late-breaking session on the final day of the meeting. “Analysis of the Early Outcomes in the ROADSTER-2 Clinical Trial of Transcarotid Artery Revascularization in Patients with Significant Carotid Artery Disease”will be presented by Dr. Vikram Kashyap of University Hospitals Case Medical Center (Cleveland) on Saturday, June 15 at 1:50 p.m. ET in Potomac D, 4-6. In addition, Silk Road Medical will be hosting TCAR @ Vascular Live on Thursday, June 13 from 3-3:30 p.m. ET in Exhibit Hall B. “Latest Clinical Evidence Strongly Supports Developing a TCAR Program – Why and How from a Vascular Surgery Perspective” will be presented by Dr. Marc Schermerhorn of Beth Israel Deaconess Medical Center, Dr. Jeffrey Jim of University of Washington School of Medicine (St. Louis), Dr. Michael Stoner of the University of Rochester and Dr. Sumaira Macdonald of Silk Road Medical. Silk Road Medical will be exhibiting in booth #301. About TCAR with the ENROUTE Transcarotid Neuroprotection and Stent System About Silk Road Medical ENROUTE is a registered trademark of Silk Road Medical, Inc. |
|